We partnered with Sifted’s on their latest ranking, which features 20 early-stage “Cancer tech “ start-ups across Europe that are making waves in the industry.
Sifted scouted hundreds of early-stage oncology startups to map out the cream of the crop, scanning all rounds up to seed stage and young unfunded companies with a cancer focus. Startups with relevant tech stacks but limited oncology focus were excluded. We then scored companies on a weighted methodology accounting for momentum, team strength, growth signals and product differentiation.
Meet the 20 seed-stage European companies that are reshaping the future of cancer care here.